Kenji Yamaji, Yoshitaka Iwanaga, Kazuyoshi Kakehi, Kosuke Fujita, Takayuki Kawamura, Chikara Hirase, Masafumi Ueno, Gaku Nakazawa. Prognostic Significance of Asymptomatic Cerebral Infarction in Patients After Cardiac Catheterization. International heart journal. 2024. 65. 1. 13-20
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
Takahide Taniguchi, Shoko Nakayama, Hirokazu Tanaka, Shinya Rai, Chikara Hirase, Yasuyoshi Morita, Yoichi Tatsumi, Takashi Ashida, Mitsuhiro Matsuda, Shigeo Hashimoto, et al. Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells. British journal of haematology. 2022. 198. 2. 360-372
Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, et al. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International journal of hematology. 2022. 115. 3. 336-349
Kenji Yamaji, Yoshitaka Iwanaga, Takayuki Kawamura, Kosuke Fujita, Masakazu Yasuda, Toru Takase, Chikara Hirase, Masafumi Ueno, Gaku Nakazawa. Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis. 2022. 80. 1. 94-100
Y. Nannya, J. Takeda, Y. Shiozawa, Y. Shiraishi, Y. Okuno, K. Kataoka, K. Chiba, H. Tanaka, M. Sanada, S. Chiba, et al. MOLECULAR MARKERS PREDICTING RESPONSE TO AZACITIDINE TREATMENT FOR MYELODYSPLASTIC SYNDROMES. HAEMATOLOGICA. 2017. 102. 98-99
June Takeda, Yusuke Shiozawa, Yuichi Shiraishi, Yusuke Okuno, Keisuke Kataoka, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Shigeru Chiba, Norio Asou, et al. Genetic Landscape and Clonal Evolution Following 5-Aza Therapy in Patients with High-Risk Myelodysplastic Syndromes. BLOOD. 2016. 128. 22